logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation.

    Article - En anglais

    Context. - The Agency for Health Care Policy and Research (AHCPR) published the Smoking Cessation : Clinical Practice Guideline in 1996.

    Based on the results of meta-analyses and expert opinion, the guideline identifies efficacious interventions for primary care clinicians and smoking cessation specialty providers.

    Objective

    - To determine the cost-effectiveness of clinical recommendations in AHCPR's guideline.

    Design

    - The guideline's 15 recommended smoking cessation interventions were analyzed to determine their relative cost-effectiveness.

    Then, using decision probabilities, the interventions were combined into a global model of the guideline's overall cost-effectiveness.

    Patients

    - The analysis assumes that primary care clinicians screen all presenting adults for smoking status and advise and motivate all smokers to quit during the course of a routine office visit or hospitalization.

    Smoking cessation interventions are provided to 75% of US smokers 18 years and older who are assumed to be willing to make a quit attempt during a year's time.

    Intervention

    - Three counseling interventions for primary care clinicians and 2 counseling interventions for smoking cessation specialists were modeled with and without transdermal nicotine and nicotine gum.

    Main Outcome Measure

    - Cost (1995 dollars) per life-year or quality-adjusted life-year (QALY) saved, at a discount of 3%. Results. - The guideline would cost $6.3 billion to implement in its first year. (...)

    Mots-clés Pascal : Tabagisme, Recommandation, Sevrage, Organisation nationale, Santé, Evaluation, Analyse avantage coût, Homme, Toxicomanie, Economie santé

    Mots-clés Pascal anglais : Tobacco smoking, Recommendation, Weaning, National organisation, Health, Evaluation, Cost benefit analysis, Human, Drug addiction, Health economy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0041618

    Code Inist : 002B30A01C. Création : 17/04/1998.